Extracellular Vesicle Infusion Therapy for Severe COVID-19

Conditions:   Covid19;   ARDS;   Pneumonia, Viral Intervention:   Biological: DB-001 Sponsor:   Direct Biologics, LLC Not yet recruiting

Source: ClinicalTrials.gov - July 30, 2020 Category: Research Source Type: clinical trials